Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000254101 | SCV000311830 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000254101 | SCV000540694 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Gene |
RCV001668526 | SCV001885834 | benign | not provided | 2018-11-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002058228 | SCV002484962 | benign | 46,XY sex reversal 9 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002058228 | SCV002514100 | benign | 46,XY sex reversal 9 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002244630 | SCV002514101 | benign | Tetralogy of Fallot | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000254101 | SCV003928347 | benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing |